India's 1st Needle-free Nasal Vaccine ‘iNCOVACC’ Now Available as Booster

India's 1st Needle-free Nasal Vaccine ‘iNCOVACC’ Now Available as Booster

A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC is now available on CoWin application for Rs 800, while Rs 325 has been fixed for purchase in government facilities.

Moneycontrol quoted top government sources as saying that Rs 800 is apart from 5 percent Goods and Services Tax (GST) in private hospitals. Provided that private hospitals are permitted to charge up to Rs 150 as an administrative charge for every dose of the Covid-19 vaccine, one dose of this vaccine developed on a technology licensed by the Washington University in St Louis may cost about Rs 1,000 for every recipient.

The intranasal vaccine, which has been earlier approved both as a booster shot for those fully vaccinated with Covaxin or Covishield, as well as a primary vaccine for a full two-dose course against Covid-19, would be available at private vaccination centres by the end of January.

“We have achieved the goals we set for ourselves during this pandemic. We have developed Covaxin and Inovacc, two Covid vaccines from two different platforms, with two different delivery systems. The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics," Bharat Biotech Executive Chairman Dr Krishna Ella said in a statement.

Stay connected to Jaano Junction on Instagram, Facebook, YouTube, Twitter and Koo. Listen to our Podcast on Spotify or Apple Podcasts.

Jaano Junction